{
  "ticker": "SLN",
  "company_name": "Silence Therapeutics Plc - Amer",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04718844",
      "title": "A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome",
      "start_date": "2021-04-14",
      "completion_date": "2023-05-23",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics plc"
    },
    {
      "nct_id": "NCT04606602",
      "title": "Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Hyperlipidemias, Dyslipidemias, Elevated Lp(a)",
      "start_date": "2020-11-18",
      "completion_date": "2023-08-23",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics plc"
    },
    {
      "nct_id": "NCT04559971",
      "title": "A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "EARLY_PHASE1",
      "condition": "Healthy Volunteers",
      "start_date": "2020-09-03",
      "completion_date": "2021-03-23",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics plc"
    },
    {
      "nct_id": "NCT05537571",
      "title": "Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a)",
      "start_date": "2022-12-13",
      "completion_date": "2024-07-01",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics plc"
    },
    {
      "nct_id": "NCT05499013",
      "title": "Study to Assess SLN124 in Patients With Polycythemia Vera",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1, PHASE2",
      "condition": "Polycythemia Vera",
      "start_date": "2023-01-26",
      "completion_date": "2030-03",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics plc"
    },
    {
      "nct_id": "NCT04176653",
      "title": "Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124",
      "status": "WITHDRAWN",
      "phase": "PHASE1",
      "condition": "Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome",
      "start_date": "2019-08-20",
      "completion_date": "2021-10-14",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics plc"
    },
    {
      "nct_id": "NCT00938574",
      "title": "Study With Atu027 in Patients With Advanced Solid Cancer",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Advanced Solid Tumors",
      "start_date": "2009-06",
      "completion_date": "2012-09",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics GmbH"
    },
    {
      "nct_id": "NCT01808638",
      "title": "Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Carcinoma, Pancreatic Ductal",
      "start_date": "2013-03",
      "completion_date": "2016-01",
      "enrollment": 0,
      "sponsor": "Silence Therapeutics GmbH"
    }
  ],
  "summary": {
    "total_trials": 8,
    "by_phase": {
      "PHASE1": 4,
      "EARLY_PHASE1": 1,
      "PHASE2": 1,
      "PHASE1, PHASE2": 2
    },
    "by_status": {
      "COMPLETED": 6,
      "ACTIVE_NOT_RECRUITING": 1,
      "WITHDRAWN": 1
    },
    "active_trials": 1,
    "completed_trials": 6,
    "conditions": [
      "Advanced Solid Tumors",
      "Carcinoma, Pancreatic Ductal",
      "Cardiovascular Diseases, Atherosclerosis, Lipoprotein(a)",
      "Healthy Volunteers",
      "Hyperlipidemias, Dyslipidemias, Elevated Lp(a)",
      "Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome",
      "Non-transfusion-dependent Thalassemia, Low Risk Myelodysplastic Syndrome, Very-Low Risk Myelodysplastic Syndrome",
      "Polycythemia Vera"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:21:56.096388",
    "search_query": "Silence Therapeutics Plc - Amer",
    "url": "https://clinicaltrials.gov/search?term=Silence+Therapeutics+Plc+-+Amer"
  }
}